Michael Weiner

Dr Michael Weiner is Abcam’s Vice President of Molecular Sciences, and has founded more than four biotech companies, including Affomix, GnuBio, and AxioMx.

Throughout his career, Dr Weiner has developed several tools widely used in molecular biology, such as the first commercial Next Generation DNA sequencing instrument, a bead-based genotyping method, and improved methods for the production of monoclonal antibodies.

Beyond his career as a scientist, Dr Weiner is a dedicated mentor to multiple bioscience professionals, and is also an inventive artist!

All contributions by Michael Weiner

article

Under the Microscope: What is PCR and how is it used to detect SARS-CoV-2?

December 4, 2020 by Michael Weiner

What is PCR? Polymerase Chain Reactions (PCRs) are often used in research to amplify genetic material, and, as a scientist, you probably don’t give the process a second...

article

Under the Microscope: what are DNA, RNA, and proteins?

August 28, 2020 by Michael Weiner

What are DNA, RNA, and proteins? “Well, that’s easy,” you may be thinking. “DNA is made from four bases, is in the shape of a right-handed double helix,...

article